The 10 latest articles on Gastroenterology & Hepatology come from 7 sources, published between Oct 8 and Nov 13. Most come from NutraIngredients.com (3) and newswise.com (2).
People in these stories: Jeffrey Gordon (3), Prof Gordon (3)
Organizations: Washington University (3), IBD (2)
Places: St. Louis (3), Lactobacillus (2)
Medicare Part B Coverage Confirmed Nationwide CMS Issued Temporary C-Code Specific for Qutenza Commercial Payer Coverage and Hospital Formulary Acceptance Advancing News provided by NeurogesX, Inc. Jul 27, 2010, 05:43 ET SAN MATEO, Calif., July 27 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company…
Getty Images Feature Harnessing the Power of Microbiome-Based Therapies Microbiome-based therapies restore healthy microbes and metabolic networks to promote health by manipulating microbial communities and restoring balance. By Alivia Kaylor, MSc Published: 23 Jan 2024 In recent years, the microbiome — a vast…
SYSTEM NOTICE Auto translation by AI. Be sure, accuracy, nuances and authorial intent may not be fully reflected.Show originalUnderstanding Gut Environment and Fermented Foods Series: Basics of Gut Bacteria You Need to Know to Make Fermented Foods Your Ally…
Newswise — The September issue of The American Journal of Gastroenterology features a new ACG clinical guideline on Perioperative Risk Assessment and Management in Patients With Cirrhosis. Recognizing the unique surgical risks in these patients, the guideline recommends a multidisciplinary approach…
Newswise — Colistin is a last-resort antibiotic critical for treating multidrug-resistant bacterial infections. Resistance to colistin heralds the emergence of truly pan-resistant infections. In the article, the researchers found combining colistin with inhibitors of biotin (vitamin B7) or fatty acid production can…
Project description DE EN ES FR IT PL In situ 4D bioprinting of colorectal mucosa and submucosa Inflammation of the mucosa and submucosa layers of the anus, rectum and colon are characteristic of colorectal diseases. In severe cases, removal of the…
This is a paid press release. Contact the press release distributor directly with any inquiries. Fortress Biotech Announces an Exclusive License Agreement for FB-607 for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) Fortress Biotech, Inc. Tue, November 10, 2026 at…
Significantly more participants in the probiotic group achieved the end point of losing at least three percent of body weight by the end of the study, compared to the placebo group, reported researchers led by Pierre Déchelotte, professor of nutrition…
However, no significant impact was observed for body mass index (BMI) or waist-to-hip (W/H) ratio, Dr Harriët Schellekens and her co-workers wrote in EBioMedicine. The data represents a partial translation of results from mice to humans: The mouse data indicated…
Scientists from the Catholic University of Louvain report that Dysosmobacter welbionis J115T is found in up to 70% of the healthy population, and that lower abundance is correlated to higher BMI, fasting glucose levels, and higher HbA1c (glycated hemoglobin, a marker of long-term…
Gut health, IBD/IBS, reflux, liver disease, and microbiome research.
An article joins this feed when it matches these terms. Each one is also a search of its own.